WealthBridge Capital Management’s Gilead Sciences GILD Stock Holding History

WealthBridge Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,173	Closed	-$222K	–	171
2021 Q3	$222K	Hold	3,173	–	–	0.08%	156
2021 Q2	$218K	Sell	3,173 -100	-3%	-$6.68K	0.08%	157
2021 Q1	$212K	Sell	3,273 -179	-5%	-$11.5K	0.09%	150
2020 Q4	$201K	Sell	3,452 -78	-2%	-$4.71K	0.09%	141
2020 Q3	$223K	Sell	3,530 -19	-0.5%	-$1.32K	0.11%	118
2020 Q2	$273K	Buy	3,549 +92	+3%	+$7.05K	0.15%	99
2020 Q1	$258K	Buy	+3,457	New	+$239K	0.18%	90
2019 Q2	–	Sell	-2,848	Closed	-$188K	–	397
2019 Q1	$188K	Sell	2,848 -208	-7%	-$13.8K	0.12%	114
2018 Q4	$191K	Buy	+3,056	New	+$214K	0.15%	105

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WealthBridge Capital Management's GILD Position: Q4 2021 in Review

WealthBridge Capital Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 3,173 shares — an estimated $222K sold.

WealthBridge Capital Management first reported a position in GILD in Q4 2018 and held it in 9 quarters. The position peaked at $273K in Q2 2020. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

WealthBridge Capital Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
WealthBridge Capital Management sold 3,173 Gilead Sciences shares in Q4 2021, an estimated $222K.
WealthBridge Capital Management first reported a position in Gilead Sciences in Q4 2018 and held it in 9 quarters.
WealthBridge Capital Management's Gilead Sciences position peaked at $273K in Q2 2020.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on WealthBridge Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.